BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33433941)

  • 1. Inducible CRISPR-dCas9 Transcriptional Systems for Sensing and Genome Regulation.
    Wu H; Wang F; Jiang JH
    Chembiochem; 2021 Jun; 22(11):1894-1900. PubMed ID: 33433941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing.
    Moradpour M; Abdulah SNA
    Plant Biotechnol J; 2020 Jan; 18(1):32-44. PubMed ID: 31392820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of a Synthetic Amino Acid into dCas9 Improves Control of Gene Silencing.
    Koopal B; Kruis AJ; Claassens NJ; Nobrega FL; van der Oost J
    ACS Synth Biol; 2019 Feb; 8(2):216-222. PubMed ID: 30668910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing CRISPR System for Transcriptional Activation.
    Chen M; Qi LS
    Adv Exp Med Biol; 2017; 983():147-157. PubMed ID: 28639197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer.
    Mohamad Zamberi NN; Abuhamad AY; Low TY; Mohtar MA; Syafruddin SE
    CRISPR J; 2024 Apr; 7(2):73-87. PubMed ID: 38635328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-based epigenome editing: mechanisms and applications.
    Fadul SM; Arshad A; Mehmood R
    Epigenomics; 2023 Nov; 15(21):1137-1155. PubMed ID: 37990877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/dCas9 Switch Systems for Temporal Transcriptional Control.
    Gjaltema RAF; Schulz EG
    Methods Mol Biol; 2018; 1767():167-185. PubMed ID: 29524134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants.
    Ding X; Yu L; Chen L; Li Y; Zhang J; Sheng H; Ren Z; Li Y; Yu X; Jin S; Cao J
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
    Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-assisted transcription activation by phase-separation proteins.
    Liu J; Chen Y; Nong B; Luo X; Cui K; Li Z; Zhang P; Tan W; Yang Y; Ma W; Liang P; Songyang Z
    Protein Cell; 2023 Dec; 14(12):874-887. PubMed ID: 36905356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9.
    Wang Y; Zhang ZT; Seo SO; Lynn P; Lu T; Jin YS; Blaschek HP
    Biotechnol Bioeng; 2016 Dec; 113(12):2739-2743. PubMed ID: 27240718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex.
    He M; Zhou X; Li Z; Yin X; Han W; Zhou J; Sun X; Liu X; Yao D; Liang H
    J Am Chem Soc; 2022 Jul; 144(28):12690-12697. PubMed ID: 35792375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart.
    Schoger E; Carroll KJ; Iyer LM; McAnally JR; Tan W; Liu N; Noack C; Shomroni O; Salinas G; Groß J; Herzog N; Doroudgar S; Bassel-Duby R; Zimmermann WH; Zelarayán LC
    Circ Res; 2020 Jan; 126(1):6-24. PubMed ID: 31730408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies.
    Jensen ED; Ferreira R; Jakočiūnas T; Arsovska D; Zhang J; Ding L; Smith JD; David F; Nielsen J; Jensen MK; Keasling JD
    Microb Cell Fact; 2017 Mar; 16(1):46. PubMed ID: 28298224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lo A; Qi L
    F1000Res; 2017; 6():. PubMed ID: 28649363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
    Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
    J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
    Xu X; Qi LS
    J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.